Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: The TROUP Study
about
Interventions for the reduction of prescribed opioid use in chronic non-cancer painInterventions for the reduction of prescribed opioid use in chronic non-cancer painPersonalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challengesThe downward spiral of chronic pain, prescription opioid misuse, and addiction: cognitive, affective, and neuropsychopharmacologic pathwaysSafety concerns with long-term opioid use.Attentional bias for prescription opioid cues among opioid dependent chronic pain patientsUsing electronic health records data to identify patients with chronic pain in a primary care setting.Key Data Gaps Regarding the Public Health Issues Associated with Opioid Analgesics.Harmonizing post-market surveillance of prescription drug misuse: a systematic review of observational studies using routinely collected data (2000-2013).The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: the role of opioid prescriptionLong-term use of opioids for complex chronic painPhysical pain is common and associated with nonmedical prescription opioid use among people who inject drugs.Predictors of long-term opioid treatment among patients who receive chemoradiation for head and neck cancer.An analysis of the number of multiple prescribers for opioids utilizing data from the California Prescription Monitoring Program.Comparison of the risks of shopping behavior and opioid abuse between tapentadol and oxycodone and association of shopping behavior and opioid abuse.Chronic opioid therapy urine drug testing in primary care: prevalence and predictors of aberrant resultsPatterns of opioid use for chronic noncancer pain in the Veterans Health Administration from 2009 to 2011.Survey of Primary-Care Providers on Perceived Benefits of and Barriers to PainTrackerPrescription opioid analgesics rapidly change the human brain.Elevated pain sensitivity in chronic pain patients at risk for opioid misuseOpioid use in the management of diabetic peripheral neuropathy (DPN) in a large commercially insured population.Long-term chronic opioid therapy discontinuation rates from the TROUP studyThe Contribution of Differential Opioid Responsiveness to Identification of Opioid Risk in Chronic Pain Patients.Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors.A Pilot Study To Define Chemical Coping in Cancer Patients Using the Delphi Method.Mental health disorders and long-term opioid use among adolescents and young adults with chronic pain.Frequency, Predictors, and Medical Record Documentation of Chemical Coping Among Advanced Cancer Patients.Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuseDo patients know they are on pain medication agreements? Results from a sample of high-risk patients on chronic opioid therapy"Just Advil": Harm reduction and identity construction in the consumption of over-the-counter medication for chronic pain.Prescription Opioid Duration, Dose, and Increased Risk of Depression in 3 Large Patient Populations.Screening Community Pharmacy Patients for Risk of Prescription Opioid MisuseDeveloping a framework of care for opioid medication misuse in community pharmacy.Receipt of opioid analgesics by HIV-infected and uninfected patientsDefining Nonmedical Use of Prescription Opioids Within Health Care Claims: A Systematic Review."Safe and effective when used as directed": the case of chronic use of opioid analgesics.Applying standardized drug terminologies to observational healthcare databases: a case study on opioid exposureMedical and psychological risks and consequences of long-term opioid therapy in women.Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations.Prescribed opioid difficulties, depression and opioid dose among chronic opioid therapy patients.
P2860
Q24198272-16DF0450-3991-46F8-A571-FD91E9AA53F5Q24202027-39AA2D4A-1052-4D3F-B03D-942AE00D6E4AQ24627422-6F6D7C5E-8AB8-4CCD-B8D1-39768CF3C62BQ26824011-6734E068-0748-4E25-A84A-1AF7D5578EE6Q30251602-3E07ABC0-6518-4EA5-9217-B27C1D8E12D1Q30424153-C66F213B-E979-4B80-94BE-589C229F96D4Q30658465-5AB67834-32C1-4BBE-B2D0-EACAF6403B75Q30760780-C6E6938A-5056-4D80-89C3-A6C6F506EBE1Q30950812-09CF40F5-B312-491B-A0E6-961DF6E1F858Q33657366-C88AAB29-0FAC-4BA0-8387-579104C35996Q33677848-452463C3-993C-4A87-8E2C-CA5E3C2DBB4CQ33742629-D6F68A82-C660-4C22-AA46-1277D4BEB418Q33777489-5B77406D-9F63-4725-B444-396F737EABCFQ33857520-83DD5BB4-BF0D-425D-B676-EE8B2CFAC81AQ34512974-B0B6F99B-8DDE-423F-87AD-D4EEDC942C4AQ34566925-42208D4A-BA14-4F6C-A03C-1ADCEDC1E9E7Q34613132-6F3A6833-0381-4559-978B-5F9AB4DEC2E5Q34871333-8CA5E2C4-C89E-4702-9108-449B10D1C618Q35112680-0F229E5A-245E-47C3-AFC6-544E88218791Q35189051-5C1FBB4E-38CA-4690-82B3-922F493A3978Q35338706-6117FD8E-483A-4E57-AE9F-12FF2ACA7BB9Q35606850-AE1A9DC6-EC69-43CE-99CF-C55CD82CF907Q35801831-9E367970-7DF7-44D9-86D6-85B8F0CF389FQ35803135-3AB34076-BEF7-4106-A347-4507B19530DDQ35910634-32D21B4C-B9D5-4DAE-9F8C-33FD1DEDF0C5Q36011633-7E1D6F4C-49B5-4389-AF7D-56B9365FE1F4Q36064856-520F9339-1E6B-4597-B867-A440513EA7F0Q36083505-1539DFD9-8707-47C9-9E09-BD80EFA336E2Q36236766-5BB2DD81-A60A-40FE-A212-43795CE326ADQ36275788-2A9387B3-EFDD-4548-AFD8-3A63F188F993Q36452126-01505974-29FA-4A84-91E9-26BE72A18802Q36496722-624F5833-5677-4998-B183-92B5651B0360Q36501353-6AEA5115-28F9-415D-9E1F-796A2432E31CQ36514613-02997857-E145-4C70-86B8-DE086A0DF50BQ36530625-93226F85-E745-4AEA-946C-ACC963470CAAQ36549016-9578B9A3-F65C-439B-B0BD-782B2EE4F8EAQ36592711-6517F53B-AC6C-4FFC-A112-BFF52A1DCC70Q36709787-33B65790-705A-4F13-8E63-E047734FA173Q36742039-98D898B9-7D91-4CF9-BEB0-4FC5795D38E7Q36880782-EED8A5D6-467B-4C37-A1A8-A778D6B9B7C8
P2860
Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: The TROUP Study
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Risks for possible and probabl ...... surance plans: The TROUP Study
@ast
Risks for possible and probabl ...... surance plans: The TROUP Study
@en
type
label
Risks for possible and probabl ...... surance plans: The TROUP Study
@ast
Risks for possible and probabl ...... surance plans: The TROUP Study
@en
prefLabel
Risks for possible and probabl ...... surance plans: The TROUP Study
@ast
Risks for possible and probabl ...... surance plans: The TROUP Study
@en
P2093
P2860
P1433
P1476
Risks for possible and probabl ...... surance plans: The TROUP Study
@en
P2093
Andrea Devries
Bradley C Martin
Jennifer Brennan Braden
Mark D Sullivan
Mark J Edlund
Ming-Yu Fan
P2860
P304
P356
10.1016/J.PAIN.2010.05.020
P407
P577
2010-06-15T00:00:00Z